TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Hong-Fei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.